| 1 | Stickler syndrome | Enrichment | COL11A1, COL2A1, COL9A1, COL9A2, COL9A3, LOXL3 | 11.50 |
| 2 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | ACTA2, BGN, COL1A1, COL3A1, COL5A1, COL5A2, EFEMP2, ELN, FBN1, FBN2, LOX, MFAP5, PLOD1, TGFB2, TGFB3 | 11.43 |
| 3 | Osteogenesis imperfecta, type iii | Enrichment | BMP1, COL1A1, COL1A2, CRTAP, P3H1, PPIB, SERPINH1 | 10.88 |
| 4 | Epidermolysis bullosa, junctional 1a, intermediate | Enrichment | COL17A1, ITGB4, LAMA3, LAMB3, LAMC2 | 10.61 |
| 5 | Junctional epidermolysis bullosa non-herlitz type | Enrichment | COL17A1, ITGB4, LAMA3, LAMB3, LAMC2 | 10.61 |
| 6 | Junctional epidermolysis bullosa | Enrichment | COL17A1, ITGA6, ITGB4, LAMA3, LAMB3, LAMC2 | 10.51 |
| 7 | Brittle bone disorder | Enrichment | BMP1, COL1A1, COL1A2, CRTAP, P3H1, PLOD2, PPIB | 10.29 |
| 8 | Osteogenesis imperfecta, type ii | Enrichment | COL1A1, COL1A2, CRTAP, P3H1, PPIB | 10.11 |
| 9 | Bethlem muscular dystrophy | Enrichment | COL12A1, COL6A1, COL6A2, COL6A3 | 9.93 |
| 10 | Ehlers-danlos syndrome | Enrichment | COL1A1, COL1A2, COL3A1, COL5A1, COL5A2, FBN2, PLOD1, TGFB2, TNXB | 9.77 |
| 11 | Autosomal recessive stickler syndrome | Enrichment | COL9A1, COL9A2, COL9A3, LOXL3 | 9.44 |
| 12 | Ullrich congenital muscular dystrophy 1a | Enrichment | COL12A1, COL6A1, COL6A2, COL6A3 | 9.31 |
| 13 | Connective tissue disease | Enrichment | COL11A1, COL12A1, COL2A1, COL5A1, COL9A1, COL9A3 | 9.16 |
| 14 | High bone mass osteogenesis imperfecta | Enrichment | BMP1, COL1A1, COL1A2 | 8.96 |
| 15 | Digenic alport syndrome | Enrichment | COL4A3, COL4A4, COL4A5 | 8.96 |
| 16 | Ehlers-danlos syndrome, classic type, 1 | Enrichment | COL1A1, COL1A2, COL5A1, COL5A2 | 8.84 |
| 17 | Classic ehlers-danlos syndrome | Enrichment | COL1A1, COL1A2, COL5A1, COL5A2 | 8.84 |
| 18 | Keratoconus | Enrichment | COL1A1, COL4A1, COL5A2, PLOD1 | 8.09 |
| 19 | Alport syndrome 3a, autosomal dominant | Enrichment | COL4A3, COL4A4, COL4A5 | 7.96 |
| 20 | Autosomal dominant alport syndrome | Enrichment | COL4A3, COL4A4, COL4A5 | 7.96 |
| 21 | Alport syndrome | Enrichment | COL4A3, COL4A4, COL4A5 | 7.96 |
| 22 | Epidermolysis bullosa, junctional 1b, severe | Enrichment | LAMA3, LAMB3, LAMC2 | 7.66 |
| 23 | Thrombophilia due to thrombin defect | Enrichment | F13A1, F13B, F2, FGA | 7.57 |
| 24 | Multiple epiphyseal dysplasia due to collagen 9 anomaly | Enrichment | COL9A1, COL9A2, COL9A3 | 7.50 |
| 25 | Collagen vi-related dystrophies | Enrichment | COL6A1, COL6A2, COL6A3 | 7.50 |
| 26 | Intermediate collagen vi-related muscular dystrophy | Enrichment | COL6A1, COL6A2, COL6A3 | 7.50 |
| 27 | Skin disease | Enrichment | COL17A1, COL7A1, ITGB4, LAMB3, LAMC2 | 7.45 |
| 28 | Dysfibrinogenemia, congenital | Enrichment | FGA, FGB, FGG | 6.83 |
| 29 | Familial dysfibrinogenemia | Enrichment | FGA, FGB, FGG | 6.83 |
| 30 | Familial hypofibrinogenemia | Enrichment | FGA, FGB, FGG | 6.83 |
| 31 | Thrombocytopenia | Enrichment | F10, F11, F8, FGG, PROS1, THBD | 6.69 |
| 32 | Osteogenesis imperfecta, type iv | Enrichment | COL1A1, COL1A2, CRTAP, PPIB | 6.43 |
| 33 | Kidney disease | Enrichment | COL4A3, COL4A4, COL4A5 | 6.31 |
| 34 | Afibrinogenemia, congenital | Enrichment | FGA, FGB, FGG | 6.22 |
| 35 | Myopia | Enrichment | COL11A1, COL2A1, COL4A4, P3H2 | 6.15 |
| 36 | Epidermolysis bullosa | Enrichment | COL7A1, ITGA6, LAMB3 | 6.09 |
| 37 | Bethlem myopathy 1a | Enrichment | COL6A1, COL6A2, COL6A3 | 5.96 |
| 38 | Intervertebral disc disease | Enrichment | COL11A1, COL9A2, COL9A3 | 5.96 |
| 39 | Ehlers-danlos syndrome, arthrochalasia type, 2 | Enrichment | COL1A1, COL1A2 | 5.94 |
| 40 | Ehlers-danlos/osteogenesis imperfecta syndrome | Enrichment | COL1A1, COL1A2 | 5.94 |
| 41 | X-linked diffuse leiomyomatosis-alport syndrome | Enrichment | COL4A5, COL4A6 | 5.94 |
| 42 | Familial porencephaly | Enrichment | COL4A1, COL4A2, COLGALT1 | 5.94 |
| 43 | Marfan syndrome | Enrichment | COL2A1, FBN1, FBN2, LTBP2, TGFB2 | 5.80 |
| 44 | Cerebral palsy | Enrichment | COL4A1, COL4A2, F2, F8, PROC | 5.71 |
| 45 | Osteogenesis imperfecta, type i | Enrichment | COL1A1, COL1A2, P4HB | 5.64 |
| 46 | Hematuria, benign familial, 1 | Enrichment | COL4A3, COL4A4 | 5.47 |
| 47 | Cutis laxa | Enrichment | COL5A1, EFEMP1, EFEMP2, LOX, LTBP4 | 5.32 |
| 48 | Ehlers-danlos syndrome, arthrochalasia type, 1 | Enrichment | COL1A1, COL1A2 | 5.16 |
| 49 | Brain small vessel disease 1 with or without ocular anomalies | Enrichment | COL4A1, COL4A2 | 5.16 |
| 50 | Alport syndrome 2, autosomal recessive | Enrichment | COL4A3, COL4A4 | 5.16 |
| 51 | Autosomal recessive alport syndrome | Enrichment | COL4A3, COL4A4 | 5.16 |
| 52 | Osteogenesis imperfecta with normal sclerae, dominant form | Enrichment | COL1A1, COL1A2 | 5.16 |
| 53 | Otospondylomegaepiphyseal dysplasia, autosomal recessive | Enrichment | COL11A2, COL2A1 | 4.99 |
| 54 | Otospondylomegaepiphyseal dysplasia, autosomal dominant | Enrichment | COL11A2, COL2A1 | 4.99 |
| 55 | Fibrochondrogenesis | Enrichment | COL11A1, COL11A2 | 4.99 |
| 56 | Stickler syndrome, type ii | Enrichment | COL11A1, COL1A1 | 4.99 |
| 57 | Primary bone dysplasia | Enrichment | COL1A1, COL1A2, CTSK | 4.93 |
| 58 | Muscular dystrophy, duchenne type | Enrichment | DMD, LTBP4, UTRN | 4.89 |
| 59 | Autosomal recessive cutis laxa type i | Enrichment | EFEMP2, FBLN5, LTBP1 | 4.89 |
| 60 | Nephrotic syndrome | Enrichment | COL4A3, COL4A4, COL4A5 | 4.88 |
| 61 | Osteochondrodysplasia | Enrichment | COL1A1, COL1A2, CTSK | 4.79 |
| 62 | Hemorrhage, intracerebral | Enrichment | COL4A1, COL4A2 | 4.77 |
| 63 | Amelogenesis imperfecta, type ia | Enrichment | COL17A1, LAMB3 | 4.72 |
| 64 | Metaphyseal anadysplasia | Enrichment | MMP13, MMP9 | 4.72 |
| 65 | Localized junctional epidermolysis bullosa, non-herlitz type | Enrichment | COL17A1, ITGB4 | 4.72 |
| 66 | Recessive dystrophic epidermolysis bullosa | Enrichment | COL7A1, MMP1 | 4.66 |
| 67 | Hemophilia b | Enrichment | F8, F9 | 4.54 |
| 68 | Factor xiii deficiency | Enrichment | F13A1, F13B | 4.54 |
| 69 | Telecanthus | Enrichment | COL11A1, COL5A2 | 4.51 |
| 70 | Ehlers-danlos syndrome, classic type, 2 | Enrichment | COL5A1, COL5A2 | 4.51 |
| 71 | Myopathy | Enrichment | ACTA1, CAPN3, COL6A1, COL6A2, COL6A3, DMD, FBN1 | 4.46 |
| 72 | Autosomal recessive limb-girdle muscular dystrophy | Enrichment | CAPN3, SGCA, SGCB, SGCD, SGCG | 4.22 |
| 73 | Multicentric osteolysis, nodulosis, and arthropathy | Enrichment | MMP14, MMP2 | 4.18 |
| 74 | Cole-carpenter syndrome | Enrichment | CRTAP, P4HB | 4.14 |
| 75 | Hypertension | Enrichment | COL4A4, COL4A5, F12 | 4.10 |
| 76 | Factor x deficiency | Enrichment | F10, F11 | 4.07 |
| 77 | Cerebral sinovenous thrombosis | Enrichment | F2, F5 | 4.07 |
| 78 | Congenital factor x deficiency | Enrichment | F10, F11 | 4.07 |
| 79 | Chronic kidney disease | Enrichment | COL4A4, COL4A5 | 4.05 |
| 80 | Retinal detachment | Enrichment | COL2A1, COL9A3 | 3.99 |
| 81 | Spondyloepimetaphyseal dysplasia, strudwick type | Enrichment | COL2A1, FN1 | 3.99 |
| 82 | Spondylometaphyseal dysplasia, corner fracture type | Enrichment | COL2A1, FN1 | 3.99 |
| 83 | Aortic dissection | Enrichment | COL3A1, FBN1 | 3.99 |
| 84 | Osteoporosis | Enrichment | COL1A1, COL1A2 | 3.99 |
| 85 | Postsynaptic congenital myasthenic syndromes | Enrichment | AGRN, COL13A1, LRP4, MUSK | 3.90 |
| 86 | Hemophilia a | Enrichment | F8, F9 | 3.77 |
| 87 | Factor viii deficiency | Enrichment | F8, F9 | 3.77 |
| 88 | Anterior segment dysgenesis | Enrichment | COL4A1, PXDN | 3.76 |
| 89 | Muscular dystrophy | Enrichment | CAPN3, COL6A2, DMD, SGCA, SGCD | 3.69 |
| 90 | Focal segmental glomerulosclerosis | Enrichment | COL4A4, COL4A5 | 3.67 |
| 91 | Inguinal hernia | Enrichment | COL5A1, EFEMP1, FBN1 | 3.62 |
| 92 | Fetomaternal alloimmune thrombocytopenia 1 | Enrichment | ITGA2, ITGA2B, ITGB3 | 3.62 |
| 93 | Multiple sclerosis | Enrichment | DST, ITGB4, LAMA5, LAMB1 | 3.61 |
| 94 | Epidermolysis bullosa, junctional 5b, with pyloric atresia | Enrichment | ITGA6, ITGB4 | 3.54 |
| 95 | Contractural arachnodactyly, congenital | Enrichment | FBN1, FBN2 | 3.51 |
| 96 | Mccune-albright syndrome | Enrichment | COL2A1, FBN1 | 3.51 |
| 97 | Creatine phosphokinase, elevated serum | Enrichment | CAPN3, DAG1, DMD, LAMA2 | 3.36 |
| 98 | Isolated elevated serum creatine phosphokinase levels | Enrichment | CAPN3, DAG1, DMD, LAMA2 | 3.36 |
| 99 | Acromicric dysplasia | Enrichment | FBN1, LTBP3 | 3.26 |
| 100 | Epiphyseal dysplasia, multiple, 1 | Enrichment | COL1A1, COMP | 3.26 |
| 101 | Ehlers-danlos syndrome, hypermobility type | Enrichment | COL3A1, TNXB | 3.26 |
| 102 | Dermatofibrosarcoma protuberans | Enrichment | COL1A1, PDGFB | 3.26 |
| 103 | Preterm premature rupture of the membranes | Enrichment | MMP8, SERPINH1 | 3.26 |
| 104 | Loeys-dietz syndrome 4 | Enrichment | TGFB2, TGFB3 | 3.26 |
| 105 | Baraitser-winter cerebrofrontofacial syndrome | Enrichment | ACTB, ACTG1 | 3.26 |
| 106 | Dentinogenesis imperfecta | Enrichment | COL1A2, DSPP | 3.26 |
| 107 | Malignant peripheral nerve sheath tumor with perineurial differentiation | Enrichment | HTRA1, SH3PXD2A | 3.26 |
| 108 | Malignant triton tumor | Enrichment | HTRA1, SH3PXD2A | 3.26 |
| 109 | Dilated cardiomyopathy | Enrichment | ACTA1, ACTC1, DMD, DTNA, FBN1, LAMA2, SGCB, SGCD | 3.25 |
| 110 | Orthostatic intolerance | Enrichment | COL5A1, FBN1, PLOD1 | 3.18 |
| 111 | Familial thoracic aortic aneurysm and dissection | Enrichment | COL3A1, LOX | 3.17 |
| 112 | Spastic paraplegia 4, autosomal dominant | Enrichment | COL3A1, FGG | 3.11 |
| 113 | Amelogenesis imperfecta, type ie | Enrichment | COL17A1, LAMB3 | 3.07 |
| 114 | Cataract | Enrichment | COL18A1, COL5A1 | 3.04 |
| 115 | Loeys-dietz syndrome | Enrichment | FBN1, TGFB2, TGFB3 | 3.02 |
| 116 | Epidermolysis bullosa dystrophica, pretibial | Enrichment | COL7A1 | 2.96 |
| 117 | Epidermolysis bullosa dystrophica, autosomal dominant | Enrichment | COL7A1 | 2.96 |
| 118 | Ehlers-danlos syndrome, cardiac valvular type | Enrichment | COL1A2 | 2.96 |
| 119 | Epidermolysis bullosa dystrophica, autosomal recessive | Enrichment | COL7A1 | 2.96 |
| 120 | Alport syndrome 1, x-linked | Enrichment | COL4A5 | 2.96 |
| 121 | Nail disorder, nonsyndromic congenital, 8 | Enrichment | COL7A1 | 2.96 |
| 122 | Transient bullous dermolysis of the newborn | Enrichment | COL7A1 | 2.96 |
| 123 | Epidermolysis bullosa with congenital localized absence of skin and deformity of nails | Enrichment | COL7A1 | 2.96 |
| 124 | Deafness, x-linked 6 | Enrichment | COL4A6 | 2.96 |
| 125 | Combined osteogenesis imperfecta and ehlers-danlos syndrome 2 | Enrichment | COL1A2 | 2.96 |
| 126 | Porencephaly | Enrichment | COL4A1 | 2.96 |
| 127 | Epidermolysis bullosa pruriginosa | Enrichment | COL7A1 | 2.96 |
| 128 | Thyroid gland disease | Enrichment | COL7A1 | 2.96 |
| 129 | Atrial septal defect, ostium primum type | Enrichment | TLL1 | 2.96 |
| 130 | Recessive dystrophic epidermolysis bullosa-generalized other | Enrichment | COL7A1 | 2.96 |
| 131 | Asphyxia neonatorum | Enrichment | COL1A1 | 2.96 |
| 132 | Col4a1-related disorders | Enrichment | COL4A1 | 2.96 |
| 133 | Col4a1 or col4a2-related cerebral small vessel disease | Enrichment | COL4A1 | 2.96 |
| 134 | X-linked alport syndrome | Enrichment | COL4A5 | 2.96 |
| 135 | Localized dystrophic epidermolysis bullosa, acral form | Enrichment | COL7A1 | 2.96 |
| 136 | Recessive dystrophic epidermolysis bullosa inversa | Enrichment | COL7A1 | 2.96 |
| 137 | Generalized dominant dystrophic epidermolysis bullosa | Enrichment | COL7A1 | 2.96 |
| 138 | Stroke, ischemic | Enrichment | F2, F5 | 2.90 |
| 139 | Autosomal dominant macrothrombocytopenia | Enrichment | ACTN1, ITGA2B, ITGB3 | 2.87 |
| 140 | Amelogenesis imperfecta | Enrichment | COL17A1, LAMB3 | 2.84 |
| 141 | Beckwith-wiedemann syndrome | Enrichment | COL6A1, COL7A1 | 2.82 |
| 142 | Heart, malformation of | Enrichment | COL11A2, COL2A1 | 2.82 |
| 143 | Exfoliation syndrome | Enrichment | LOXL1, LTBP2 | 2.79 |
| 144 | Bleeding disorder, platelet-type, 16 | Enrichment | ITGA2B, ITGB3 | 2.79 |
| 145 | Weill-marchesani syndrome 1 | Enrichment | FBN1, LTBP2 | 2.79 |
| 146 | Autosomal dominant cutis laxa | Enrichment | ELN, FBLN5 | 2.79 |
| 147 | Geleophysic dysplasia | Enrichment | FBN1, LTBP3 | 2.79 |
| 148 | Multiple epiphyseal dysplasia | Enrichment | COL2A1, COMP | 2.79 |
| 149 | Aortic aneurysm, familial thoracic 1 | Enrichment | COL3A1, LOX | 2.77 |
| 150 | Scoliosis | Enrichment | COL2A1, CTSK, FBN1 | 2.75 |
| 151 | Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly | Enrichment | COL5A1, PLOD2 | 2.74 |
| 152 | Clubfoot | Enrichment | COL5A1, PLOD2 | 2.74 |
| 153 | Presynaptic congenital myasthenic syndromes | Enrichment | AGRN, COL13A1, LAMA5 | 2.74 |
| 154 | Epidermolysis bullosa, junctional 2c, laryngoonychocutaneous | Enrichment | LAMA3 | 2.66 |
| 155 | Bruck syndrome 1 | Enrichment | COL1A2 | 2.66 |
| 156 | Specific language impairment 5 | Enrichment | COL4A4 | 2.66 |
| 157 | Osteogenesis imperfecta, type xiii | Enrichment | BMP1 | 2.66 |
| 158 | Atrial septal defect 6 | Enrichment | TLL1 | 2.66 |
| 159 | Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1 | Enrichment | COL4A2 | 2.66 |
| 160 | Combined osteogenesis imperfecta and ehlers-danlos syndrome 1 | Enrichment | COL1A1 | 2.66 |
| 161 | Epidermolysis bullosa, junctional 3b, severe | Enrichment | LAMC2 | 2.66 |
| 162 | Epidermolysis bullosa, junctional 3a, intermediate | Enrichment | LAMC2 | 2.66 |
| 163 | Epidermolysis bullosa, junctional 2a, intermediate | Enrichment | LAMA3 | 2.66 |
| 164 | Glomerulonephritis | Enrichment | COL4A4 | 2.66 |
| 165 | Epidermolysis bullosa, junctional 2b, severe | Enrichment | LAMA3 | 2.66 |
| 166 | Epidermolysis bullosa dystrophica | Enrichment | COL7A1 | 2.66 |
| 167 | Anterior segment dysgenesis 7 | Enrichment | PXDN | 2.58 |
| 168 | Myopia 28, autosomal recessive | Enrichment | LOXL3 | 2.58 |
| 169 | Aortic aneurysm, familial thoracic 10 | Enrichment | LOX | 2.58 |
| 170 | Intellectual developmental disorder, autosomal dominant 39 | Enrichment | PXDN | 2.58 |
| 171 | Brachydactyly, type a2 | Enrichment | BMP2, GDF5 | 2.50 |
| 172 | Weill-marchesani syndrome | Enrichment | FBN1, LTBP2 | 2.50 |
| 173 | Pseudomyogenic hemangioendothelioma | Enrichment | ACTB, SERPINE1 | 2.50 |
| 174 | Stickler syndrome, type i | Enrichment | COL2A1 | 2.49 |
| 175 | Epiphyseal dysplasia, multiple, with myopia and conductive deafness | Enrichment | COL2A1 | 2.49 |
| 176 | Spondylometaphyseal dysplasia, algerian type | Enrichment | COL2A1 | 2.49 |
| 177 | Deafness, autosomal recessive 53 | Enrichment | COL11A2 | 2.49 |
| 178 | Osteoarthritis with mild chondrodysplasia | Enrichment | COL2A1 | 2.49 |
| 179 | Avascular necrosis of femoral head, primary, 1 | Enrichment | COL2A1 | 2.49 |
| 180 | Czech dysplasia | Enrichment | COL2A1 | 2.49 |
| 181 | Corneal dystrophy, posterior polymorphous, 2 | Enrichment | COL8A2 | 2.49 |
| 182 | Marshall syndrome | Enrichment | COL11A1 | 2.49 |
| 183 | Kniest dysplasia | Enrichment | COL2A1 | 2.49 |
| 184 | Corneal dystrophy, fuchs endothelial, 1 | Enrichment | COL8A2 | 2.49 |
| 185 | Platyspondylic lethal skeletal dysplasia, torrance type | Enrichment | COL2A1 | 2.49 |
| 186 | Fibrochondrogenesis 1 | Enrichment | COL11A1 | 2.49 |
| 187 | Spondyloepiphyseal dysplasia, stanescu type | Enrichment | COL2A1 | 2.49 |
| 188 | Acrogeria, gottron type | Enrichment | COL3A1 | 2.49 |
| 189 | Epiphyseal dysplasia, multiple, 6 | Enrichment | COL9A1 | 2.49 |
| 190 | Achondrogenesis, type ii | Enrichment | COL2A1 | 2.49 |
| 191 | Myasthenic syndrome, congenital, 19 | Enrichment | COL13A1 | 2.49 |
| 192 | Epiphyseal dysplasia, multiple, 2 | Enrichment | COL9A2 | 2.49 |
| 193 | Ullrich congenital muscular dystrophy 1b | Enrichment | COL6A2 | 2.49 |
| 194 | Spondyloperipheral dysplasia | Enrichment | COL2A1 | 2.49 |
| 195 | Myosclerosis, autosomal recessive | Enrichment | COL6A2 | 2.49 |
| 196 | Ullrich congenital muscular dystrophy 1c | Enrichment | COL6A3 | 2.49 |
| 197 | Deafness, autosomal dominant 37 | Enrichment | COL11A1 | 2.49 |
| 198 | Epiphyseal dysplasia, multiple, 3 | Enrichment | COL9A3 | 2.49 |
| 199 | Deafness, autosomal dominant 13 | Enrichment | COL11A2 | 2.49 |
| 200 | Stickler syndrome, type i, nonsyndromic ocular | Enrichment | COL2A1 | 2.49 |
| 201 | Stickler syndrome, type iv | Enrichment | COL9A1 | 2.49 |
| 202 | Fibrochondrogenesis 2 | Enrichment | COL11A2 | 2.49 |
| 203 | Dystonia 27 | Enrichment | COL6A3 | 2.49 |
| 204 | Stickler syndrome, type v | Enrichment | COL9A2 | 2.49 |
| 205 | Qualitative or quantitative defects of collagen 6 | Enrichment | COL6A2 | 2.49 |
| 206 | Vitreoretinopathy with phalangeal epiphyseal dysplasia | Enrichment | COL2A1 | 2.49 |
| 207 | Bethlem myopathy 1b | Enrichment | COL6A2 | 2.49 |
| 208 | Fibrosis of extraocular muscles, congenital, 5 | Enrichment | COL25A1 | 2.49 |
| 209 | Late-onset junctional epidermolysis bullosa | Enrichment | COL17A1 | 2.49 |
| 210 | Bethlem myopathy 1c | Enrichment | COL6A3 | 2.49 |
| 211 | Retinal lattice degeneration | Enrichment | COL9A3 | 2.49 |
| 212 | Autosomal dominant rhegmatogenous retinal detachment | Enrichment | COL2A1 | 2.49 |
| 213 | Multiple epiphyseal dysplasia with myopia and deafness | Enrichment | COL2A1 | 2.49 |
| 214 | Hypochondrogenesis | Enrichment | COL2A1 | 2.49 |
| 215 | Pneumothorax | Enrichment | COL5A1 | 2.49 |
| 216 | Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome | Enrichment | COL11A1 | 2.49 |
| 217 | Dysspondyloenchondromatosis | Enrichment | COL2A1 | 2.49 |
| 218 | Cystic lymphangioma | Enrichment | COL11A2 | 2.49 |
| 219 | Abdominal aortic aneurysm | Enrichment | COL3A1 | 2.49 |
| 220 | Type 2 collagen-related bone disorder | Enrichment | COL2A1 | 2.49 |
| 221 | Retinal arteries, tortuosity of | Enrichment | COL4A1 | 2.48 |
| 222 | Nail disorder, nonsyndromic congenital, 4 | Enrichment | COL7A1 | 2.48 |
| 223 | Caffey disease | Enrichment | COL1A1 | 2.48 |
| 224 | Brain small vessel disease 2 | Enrichment | COL4A2 | 2.48 |
| 225 | Microangiopathy and leukoencephalopathy, pontine, autosomal dominant | Enrichment | COL4A1 | 2.48 |
| 226 | Pilarowski-bjornsson syndrome | Enrichment | COL4A3 | 2.48 |
| 227 | Alport syndrome 3b, autosomal recessive | Enrichment | COL4A3 | 2.48 |
| 228 | Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps | Enrichment | COL4A1 | 2.48 |
| 229 | Hematuria, benign familial, 2 | Enrichment | COL4A3 | 2.48 |
| 230 | Hyperpigmentation of the skin | Enrichment | COL7A1 | 2.48 |
| 231 | Stargardt disease 1 | Enrichment | COL18A1, COL2A1 | 2.37 |
| 232 | Phenylketonuria | Enrichment | COL1A1 | 2.35 |
| 233 | Schizencephaly | Enrichment | COL4A1 | 2.35 |
| 234 | Epidermolytic hyperkeratosis | Enrichment | COL7A1 | 2.35 |
| 235 | Rare x-linked non-syndromic sensorineural deafness type dfn | Enrichment | COL4A6 | 2.35 |
| 236 | Keratolytic winter erythema | Enrichment | CTSB | 2.35 |
| 237 | Raph blood group system | Enrichment | CD151 | 2.35 |
| 238 | Epidermolysis bullosa simplex 7, with nephropathy and deafness | Enrichment | CD151 | 2.35 |
| 239 | Coronary heart disease 6 | Enrichment | MMP3 | 2.35 |
| 240 | Iron-refractory iron deficiency anemia | Enrichment | TMPRSS6 | 2.33 |
| 241 | Pycnodysostosis | Enrichment | CTSK | 2.33 |
| 242 | Cone-rod dystrophy 9 | Enrichment | ADAM9 | 2.33 |
| 243 | Cavitary optic disc anomalies | Enrichment | MMP19 | 2.33 |
| 244 | Phosphohydroxylysinuria | Enrichment | PHYKPL | 2.33 |
| 245 | Ceroid lipofuscinosis, neuronal, 10 | Enrichment | CTSD | 2.33 |
| 246 | Winchester syndrome | Enrichment | MMP14 | 2.33 |
| 247 | Alzheimer disease 18 | Enrichment | ADAM10 | 2.33 |
| 248 | Reticulate acropigmentation of kitamura | Enrichment | ADAM10 | 2.33 |
| 249 | Cole-carpenter syndrome 1 | Enrichment | P4HB | 2.31 |
| 250 | Myopia 25, autosomal dominant | Enrichment | P4HA2 | 2.31 |
| 251 | Osteogenesis imperfecta, type x | Enrichment | SERPINH1 | 2.31 |
| 252 | Hennekam lymphangiectasia-lymphedema syndrome 3 | Enrichment | ADAMTS3 | 2.31 |
| 253 | Brain small vessel disease 3 | Enrichment | COLGALT1 | 2.31 |
| 254 | Bcard syndrome | Enrichment | PLOD3 | 2.31 |
| 255 | Omphalocele | Enrichment | PLOD1 | 2.31 |
| 256 | Ventricular septal defect 1 | Enrichment | BMP2, BMP7 | 2.28 |
| 257 | Juvenile glaucoma | Enrichment | EFEMP1, LTBP2 | 2.28 |
| 258 | 3-methylglutaconic aciduria, type viii | Enrichment | LOXL3 | 2.28 |
| 259 | Thrombophilia due to protein c deficiency, autosomal dominant | Enrichment | PROC | 2.27 |
| 260 | High molecular weight kininogen deficiency | Enrichment | KNG1 | 2.27 |
| 261 | Thrombophilia, x-linked, due to factor viii defect | Enrichment | F8 | 2.27 |
| 262 | Warfarin sensitivity, x-linked | Enrichment | F9 | 2.27 |
| 263 | Angioedema, hereditary, 3 | Enrichment | F12 | 2.27 |
| 264 | Prekallikrein deficiency | Enrichment | KLKB1 | 2.27 |
| 265 | Hemolytic uremic syndrome, atypical 6 | Enrichment | THBD | 2.27 |
| 266 | Prothrombin deficiency, congenital | Enrichment | F2 | 2.27 |
| 267 | Thrombophilia due to protein s deficiency, autosomal dominant | Enrichment | PROS1 | 2.27 |
| 268 | Factor v deficiency | Enrichment | F5 | 2.27 |
| 269 | Amelogenesis imperfecta, hypomaturation type, iia1 | Enrichment | KLK4 | 2.27 |
| 270 | Thrombophilia due to protein s deficiency, autosomal recessive | Enrichment | PROS1 | 2.27 |
| 271 | Thrombophilia due to activated protein c resistance | Enrichment | F5 | 2.27 |
| 272 | Thrombophilia, x-linked, due to factor ix defect | Enrichment | F9 | 2.27 |
| 273 | Angioedema, hereditary, 6 | Enrichment | KNG1 | 2.27 |
| 274 | Thrombophilia due to protein c deficiency, autosomal recessive | Enrichment | PROC | 2.27 |
| 275 | Antithrombin iii deficiency | Enrichment | SERPINC1 | 2.27 |
| 276 | Factor xiii, b subunit, deficiency of | Enrichment | F13B | 2.27 |
| 277 | Thrombophilia due to thrombomodulin defect | Enrichment | THBD | 2.27 |
| 278 | Factor xiii, a subunit, deficiency of | Enrichment | F13A1 | 2.27 |
| 279 | Pregnancy loss, recurrent 2 | Enrichment | F2 | 2.27 |
| 280 | Protein s deficiency | Enrichment | PROS1 | 2.27 |
| 281 | Factor v atlanta bleeding disorder | Enrichment | F5 | 2.27 |
| 282 | Ichthyosis with erythrokeratoderma | Enrichment | KLK11 | 2.27 |
| 283 | Congenital fibrinogen deficiency | Enrichment | FGG | 2.27 |
| 284 | Amelogenesis imperfecta type 2a1 | Enrichment | KLK4 | 2.27 |
| 285 | Factor v leiden thrombophilia | Enrichment | F5 | 2.27 |
| 286 | Prothrombin deficiency | Enrichment | F2 | 2.27 |
| 287 | Severe hereditary thrombophilia due to congenital protein c deficiency | Enrichment | PROC | 2.27 |
| 288 | Protein c deficiency | Enrichment | PROC | 2.27 |
| 289 | Urticaria | Enrichment | F12 | 2.27 |
| 290 | Hemophilia b leyden | Enrichment | F9 | 2.27 |
| 291 | Factor v amsterdam bleeding disorder | Enrichment | F5 | 2.27 |
| 292 | Hereditary thrombophilia due to congenital protein s deficiency | Enrichment | PROS1 | 2.27 |
| 293 | F12-associated cold autoinflammatory syndrome | Enrichment | F12 | 2.27 |
| 294 | Inherited prekallikrein deficiency | Enrichment | KLKB1 | 2.27 |
| 295 | Epidermolytic hyperkeratosis 1 | Enrichment | COL7A1 | 2.26 |
| 296 | Factor vii deficiency | Enrichment | F7 | 2.25 |
| 297 | Congenital factor vii deficiency | Enrichment | F7 | 2.25 |
| 298 | Ehlers-danlos syndrome, vascular type | Enrichment | COL3A1 | 2.19 |
| 299 | Amelogenesis imperfecta, type ib | Enrichment | COL17A1 | 2.19 |
| 300 | Metaphyseal chondrodysplasia, schmid type | Enrichment | COL10A1 | 2.19 |
| 301 | Legg-calve-perthes disease | Enrichment | COL2A1 | 2.19 |
| 302 | Epithelial recurrent erosion dystrophy | Enrichment | COL17A1 | 2.19 |
| 303 | Epidermolysis bullosa, junctional 4, intermediate | Enrichment | COL17A1 | 2.19 |
| 304 | Stickler syndrome, type vi | Enrichment | COL9A3 | 2.19 |
| 305 | Fibromuscular dysplasia, multifocal | Enrichment | COL5A1 | 2.19 |
| 306 | Polymicrogyria with or without vascular-type ehlers-danlos syndrome | Enrichment | COL3A1 | 2.19 |
| 307 | Glaucoma, primary closed-angle | Enrichment | COL18A1 | 2.19 |
| 308 | Steel syndrome | Enrichment | COL27A1 | 2.19 |
| 309 | Familial avascular necrosis of the femoral head | Enrichment | COL2A1 | 2.19 |
| 310 | Cataract 16, multiple types | Enrichment | COL12A1 | 2.19 |
| 311 | Anterior segment dysgenesis 5 | Enrichment | COL4A1 | 2.18 |
| 312 | Myocardial infarction | Enrichment | F13A1, F7 | 2.18 |
| 313 | Nevus, epidermal | Enrichment | COL7A1 | 2.11 |
| 314 | Atrial septal defect 1 | Enrichment | BMP2, TGFB2 | 2.11 |
| 315 | Familial isolated dilated cardiomyopathy | Enrichment | ACTC1, DMD, LAMA4, PSEN1, SGCD | 2.11 |
| 316 | Microcephaly | Enrichment | COL4A1, COL7A1 | 2.10 |
| 317 | Metaphyseal dysplasia, spahr type | Enrichment | MMP13 | 2.05 |
| 318 | Spondyloepimetaphyseal dysplasia, missouri type | Enrichment | MMP13 | 2.05 |
| 319 | Amelogenesis imperfecta, hypomaturation type, iia2 | Enrichment | MMP20 | 2.05 |
| 320 | Epidermolysis bullosa, junctional 5a, intermediate | Enrichment | ITGB4 | 2.05 |
| 321 | Metaphyseal anadysplasia 2 | Enrichment | MMP9 | 2.05 |
| 322 | Glaucoma 3, primary congenital, a | Enrichment | PXDN | 2.03 |
| 323 | Cyclic neutropenia | Enrichment | ELANE | 2.03 |
| 324 | Neutropenia, severe congenital, x-linked | Enrichment | ELANE | 2.03 |
| 325 | Microcytic anemia | Enrichment | TMPRSS6 | 2.03 |
| 326 | Inflammatory skin and bowel disease, neonatal, 1 | Enrichment | ADAM17 | 2.03 |
| 327 | Palmoplantar keratoderma, punctate type ia | Enrichment | COL14A1 | 2.01 |
| 328 | Spondyloepiphyseal dysplasia congenita | Enrichment | COL2A1 | 2.01 |
| 329 | Megalocornea | Enrichment | COL11A1 | 2.01 |
| 330 | Hypophosphatasia, infantile | Enrichment | COL11A2 | 2.01 |
| 331 | Ullrich congenital muscular dystrophy 2 | Enrichment | COL12A1 | 2.01 |
| 332 | Bethlem myopathy 2 | Enrichment | COL12A1 | 2.01 |
| 333 | Osteogenesis imperfecta, type ix | Enrichment | PPIB | 2.01 |
| 334 | Osteogenesis imperfecta, type vii | Enrichment | CRTAP | 2.01 |
| 335 | Bruck syndrome 2 | Enrichment | PLOD2 | 2.01 |
| 336 | Osteogenesis imperfecta, type viii | Enrichment | P3H1 | 2.01 |
| 337 | Ehlers-danlos syndrome, dermatosparaxis type | Enrichment | ADAMTS2 | 2.01 |
| 338 | Myopia, high, with cataract and vitreoretinal degeneration | Enrichment | P3H2 | 2.01 |
| 339 | Short femur | Enrichment | PLOD2 | 2.01 |
| 340 | Bruck syndrome | Enrichment | PLOD2 | 2.01 |
| 341 | Short stature and advanced bone age with or without early-onset osteoarthritis and/or osteochondritis dissecans | Enrichment | ACAN | 1.99 |
| 342 | Ectopia lentis 1, isolated, autosomal dominant | Enrichment | FBN1 | 1.99 |
| 343 | Macular degeneration, age-related, 7 | Enrichment | HTRA1 | 1.99 |
| 344 | Acne inversa, familial, 1 | Enrichment | NCSTN | 1.99 |
| 345 | Lissencephaly 5 | Enrichment | LAMB1 | 1.99 |
| 346 | Weill-marchesani syndrome 2 | Enrichment | FBN1 | 1.99 |
| 347 | Geleophysic dysplasia 2 | Enrichment | FBN1 | 1.99 |
| 348 | Protrusio acetabuli | Enrichment | FBN1 | 1.99 |
| 349 | Vitreoretinopathy, neovascular inflammatory | Enrichment | CAPN5 | 1.99 |
| 350 | Cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy 2 | Enrichment | HTRA1 | 1.99 |
| 351 | Angioedema, hereditary, 4 | Enrichment | PLG | 1.99 |
| 352 | Microcornea, myopic chorioretinal atrophy, and telecanthus | Enrichment | ADAMTS18 | 1.99 |
| 353 | Macular degeneration, early-onset | Enrichment | FBN2 | 1.99 |
| 354 | Nephrotic syndrome, type 26 | Enrichment | LAMA5 | 1.99 |
| 355 | Pulmonary hypertension, primary, 6 | Enrichment | CAPNS1 | 1.99 |
| 356 | Lymphoplasmacytic lymphoma | Enrichment | FBN1 | 1.99 |
| 357 | Spondyloepimetaphyseal dysplasia, aggrecan type | Enrichment | ACAN | 1.99 |
| 358 | Spondyloepiphyseal dysplasia, kimberley type | Enrichment | ACAN | 1.99 |
| 359 | Cardiomyopathy, dilated, 1u | Enrichment | PSEN1 | 1.99 |
| 360 | Acne inversa, familial, 3 | Enrichment | PSEN1 | 1.99 |
| 361 | Oculogastrointestinal neurodevelopmental syndrome | Enrichment | CAPN15 | 1.99 |
| 362 | Bent bone dysplasia syndrome 2 | Enrichment | LAMA5 | 1.99 |
| 363 | Polycystic ovary syndrome | Enrichment | CAPN10 | 1.99 |
| 364 | Progressive muscular atrophy | Enrichment | CAPN3 | 1.99 |
| 365 | Kuhnt-junius degeneration | Enrichment | HTRA1 | 1.99 |
| 366 | Osteochondritis dissecans | Enrichment | ACAN | 1.99 |
| 367 | Htra1 disorder | Enrichment | HTRA1 | 1.99 |
| 368 | Neonatal marfan syndrome | Enrichment | FBN1 | 1.99 |
| 369 | Htra1-related autosomal dominant cerebral small vessel disease | Enrichment | HTRA1 | 1.99 |
| 370 | Qualitative or quantitative defects of calpain | Enrichment | CAPN3 | 1.99 |
| 371 | Pash syndrome | Enrichment | NCSTN | 1.99 |
| 372 | Lama5-related multisystemic syndrome | Enrichment | LAMA5 | 1.99 |
| 373 | Short stature-advanced bone age-early-onset osteoarthritis syndrome | Enrichment | ACAN | 1.99 |
| 374 | Htra1-related cerebral small vessel disease | Enrichment | HTRA1 | 1.99 |
| 375 | Sensorineural hearing loss | Enrichment | COL11A2, COL9A1 | 1.98 |
| 376 | Glanzmann thrombasthenia 1 | Enrichment | ITGA2B, ITGB3 | 1.97 |
| 377 | Early-onset autosomal dominant alzheimer disease | Enrichment | APP, PSEN1 | 1.97 |
| 378 | Kallikrein, decreased urinary activity of | Enrichment | KLK1 | 1.97 |
| 379 | Cholesteatoma, congenital | Enrichment | F13B | 1.97 |
| 380 | Factor xii deficiency | Enrichment | F12 | 1.97 |
| 381 | Bleeding disorder, east texas type | Enrichment | F5 | 1.97 |
| 382 | Factor xi deficiency | Enrichment | F11 | 1.97 |
| 383 | Surfactant metabolism dysfunction, pulmonary, 3 | Enrichment | F8 | 1.97 |
| 384 | Hereditary angioedema | Enrichment | F12 | 1.97 |
| 385 | Cholesteatoma | Enrichment | F13B | 1.97 |
| 386 | Angioedema | Enrichment | F12 | 1.97 |
| 387 | Peters-plus syndrome | Enrichment | COL4A1 | 1.96 |
| 388 | Hereditary retinal dystrophy | Enrichment | ADAM9, COL11A2, COL18A1, COL2A1, COL9A1 | 1.93 |
| 389 | Fundus dystrophy | Enrichment | ADAM9, COL11A2, COL18A1, COL2A1, COL9A1 | 1.93 |
| 390 | Ichthyosis | Enrichment | COL7A1 | 1.92 |
| 391 | Hypertelorism | Enrichment | COL11A1, COL1A1 | 1.91 |
| 392 | Rare autosomal dominant non-syndromic sensorineural deafness type dfna | Enrichment | COL11A1, COL11A2 | 1.91 |
| 393 | Pancreatitis, hereditary | Enrichment | PRSS1, PRSS2 | 1.90 |
| 394 | Arthrogryposis multiplex congenita 2, neurogenic type | Enrichment | COL25A1 | 1.89 |
| 395 | Corneal dystrophy | Enrichment | COL17A1 | 1.89 |
| 396 | Knobloch syndrome | Enrichment | COL18A1 | 1.89 |
| 397 | Epidermolysis bullosa simplex 3, localized or generalized intermediate, with bp230 deficiency | Enrichment | DST | 1.88 |
| 398 | Epidermolysis bullosa, junctional 6, with pyloric atresia | Enrichment | ITGA6 | 1.88 |
| 399 | Basal ganglia calcification, idiopathic, 1 | Enrichment | JAM2, PDGFB | 1.85 |
| 400 | Congenital muscular dystrophy | Enrichment | CAPN3, LAMA2 | 1.85 |
| 401 | Neutropenia, severe congenital, 1, autosomal dominant | Enrichment | ELANE | 1.85 |
| 402 | Nail disorder, nonsyndromic congenital, 9 | Enrichment | CTSK | 1.85 |
| 403 | Neonatal inflammatory skin and bowel disease | Enrichment | ADAM17 | 1.85 |
| 404 | Cleft soft palate | Enrichment | PLOD2 | 1.83 |
| 405 | Ehlers-danlos syndrome, kyphoscoliotic type, 1 | Enrichment | PLOD1 | 1.83 |
| 406 | Umbilical hernia | Enrichment | PLOD1 | 1.83 |
| 407 | Hennekam syndrome | Enrichment | ADAMTS3 | 1.83 |
| 408 | Plod1-related kyphoscoliotic ehlers-danlos syndrome | Enrichment | PLOD1 | 1.83 |
| 409 | Walker-warburg syndrome | Enrichment | COL4A1 | 1.81 |
| 410 | Isolated macular dystrophy | Enrichment | COL4A5 | 1.81 |
| 411 | Angioedema, hereditary, 1 | Enrichment | F12 | 1.79 |
| 412 | Knobloch syndrome 1 | Enrichment | COL18A1 | 1.79 |
| 413 | Fuchs' endothelial dystrophy | Enrichment | COL8A2 | 1.79 |
| 414 | Congenital ptosis | Enrichment | COL25A1 | 1.79 |
| 415 | Familial cerebral saccular aneurysm | Enrichment | COL3A1 | 1.79 |
| 416 | Corpus callosum, agenesis of | Enrichment | COL4A1 | 1.78 |
| 417 | Atypical hemolytic-uremic syndrome | Enrichment | COL4A5 | 1.78 |
| 418 | Isolated corpus callosum agenesis | Enrichment | COL4A1 | 1.78 |
| 419 | Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome | Enrichment | COL4A1 | 1.78 |
| 420 | Epidermolysis bullosa simplex 5c, with pyloric atresia | Enrichment | ITGB4 | 1.76 |
| 421 | Neuropathy, hereditary sensory and autonomic, type vi | Enrichment | DST | 1.76 |
| 422 | Dowling-degos disease 1 | Enrichment | ADAM10 | 1.73 |
| 423 | Developmental dysplasia of the hip 1 | Enrichment | COL2A1 | 1.71 |
| 424 | Corneal dystrophy, posterior polymorphous, 1 | Enrichment | COL8A2 | 1.71 |
| 425 | Congenital fibrosis of the extraocular muscles | Enrichment | COL25A1 | 1.71 |
| 426 | Pain disorder | Enrichment | COL5A1 | 1.71 |
| 427 | Temporal arteritis | Enrichment | P4HA2 | 1.71 |
| 428 | Patent foramen ovale | Enrichment | TLL1 | 1.70 |
| 429 | Polycystic kidney disease | Enrichment | COL4A4 | 1.70 |
| 430 | Cutis laxa, autosomal dominant 1 | Enrichment | ELN | 1.69 |
| 431 | Plasminogen deficiency, type i | Enrichment | PLG | 1.69 |
| 432 | Stiff skin syndrome | Enrichment | FBN1 | 1.69 |
| 433 | Alzheimer disease 3 | Enrichment | PSEN1 | 1.69 |
| 434 | Pick disease of brain | Enrichment | PSEN1 | 1.69 |
| 435 | Corneal dystrophy, congenital stromal | Enrichment | DCN | 1.69 |
| 436 | Lissencephaly 1 | Enrichment | LAMB1 | 1.69 |
| 437 | Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads | Enrichment | CAST | 1.69 |
| 438 | Beaulieu-boycott-innes syndrome | Enrichment | FBN1 | 1.69 |
| 439 | Schwartz-jampel syndrome, type 1 | Enrichment | HSPG2 | 1.69 |
| 440 | Spastic paraplegia 76, autosomal recessive | Enrichment | CAPN1 | 1.69 |
| 441 | Supravalvular aortic stenosis | Enrichment | ELN | 1.69 |
| 442 | Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2 | Enrichment | SCUBE3 | 1.69 |
| 443 | Marfanoid-progeroid-lipodystrophy syndrome | Enrichment | FBN1 | 1.69 |
| 444 | Trypsinogen deficiency | Enrichment | PRSS1 | 1.69 |
| 445 | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Enrichment | HTRA1 | 1.69 |
| 446 | Lens subluxation | Enrichment | FBN1 | 1.69 |
| 447 | Budd-chiari syndrome | Enrichment | F5 | 1.67 |
| 448 | Pregnancy loss, recurrent 1 | Enrichment | F5 | 1.67 |
| 449 | Hereditary angioedema with normal c1inh not related to f12 or plg variant | Enrichment | KNG1 | 1.67 |
| 450 | Epidermolysis bullosa simplex 1c, localized | Enrichment | ITGB4 | 1.66 |
| 451 | Aplasia cutis congenita | Enrichment | ITGB4 | 1.66 |
| 452 | Multiple enchondromatosis, maffucci type | Enrichment | COL2A1 | 1.65 |
| 453 | Hepatoblastoma | Enrichment | COL7A1 | 1.64 |
| 454 | Autosomal dominant severe congenital neutropenia | Enrichment | ELANE | 1.63 |
| 455 | Blood group system, landsteiner-wiener | Enrichment | ICAM4 | 1.63 |
| 456 | Carpal tunnel syndrome 1 | Enrichment | TTR | 1.63 |
| 457 | Bladder diverticulum | Enrichment | EFEMP1 | 1.63 |
| 458 | Hyperthyroxinemia, dystransthyretinemic | Enrichment | TTR | 1.63 |
| 459 | Cutis laxa, autosomal recessive, type ia | Enrichment | FBLN5 | 1.63 |
| 460 | Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma | Enrichment | LTBP2 | 1.63 |
| 461 | Pseudoachondroplasia | Enrichment | COMP | 1.63 |
| 462 | Hyperopia, high | Enrichment | NRXN1 | 1.63 |
| 463 | Hypophosphatemic rickets, autosomal recessive, 1 | Enrichment | DMP1 | 1.63 |
| 464 | Von willebrand disease, type 1 | Enrichment | VWF | 1.63 |
| 465 | Baraitser-winter syndrome 1 | Enrichment | ACTB | 1.63 |
| 466 | Muscular dystrophy, limb-girdle, autosomal recessive 6 | Enrichment | SGCD | 1.63 |
| 467 | Systemic lupus erythematosus 6 | Enrichment | ITGAM | 1.63 |
| 468 | Muscular dystrophy, becker type | Enrichment | DMD | 1.63 |
| 469 | Glaucoma 3, primary congenital, d | Enrichment | LTBP2 | 1.63 |
| 470 | Angel-shaped phalangoepiphyseal dysplasia | Enrichment | GDF5 | 1.63 |
| 471 | Glaucoma 1, open angle, h | Enrichment | EFEMP1 | 1.63 |
| 472 | Macular degeneration, age-related, 3 | Enrichment | FBLN5 | 1.63 |
| 473 | Congenital myopathy 2a, typical, autosomal dominant | Enrichment | ACTA1 | 1.63 |
| 474 | Cardiomyopathy, dilated, 1jj | Enrichment | LAMA4 | 1.63 |
| 475 | Dentinogenesis imperfecta 1 | Enrichment | DSPP | 1.63 |
| 476 | Basal ganglia calcification, idiopathic, 5 | Enrichment | PDGFB | 1.63 |
| 477 | Dentinogenesis imperfecta, shields type iii | Enrichment | DSPP | 1.63 |
| 478 | Amyloidosis, hereditary systemic 1 | Enrichment | TTR | 1.63 |
| 479 | Dentin dysplasia, type ii | Enrichment | DSPP | 1.63 |
| 480 | Von willebrand disease, type 2 | Enrichment | VWF | 1.63 |
| 481 | Muscular dystrophy-dystroglycanopathy , type a, 9 | Enrichment | DAG1 | 1.63 |
| 482 | Deafness, autosomal dominant 39, with dentinogenesis imperfecta 1 | Enrichment | DSPP | 1.63 |
| 483 | Myopathy, scapulohumeroperoneal | Enrichment | ACTA1 | 1.63 |
| 484 | Deafness, autosomal dominant 56 | Enrichment | TNC | 1.63 |
| 485 | Muscular dystrophy, limb-girdle, autosomal recessive 5 | Enrichment | SGCG | 1.63 |
| 486 | Weill-marchesani syndrome 3 | Enrichment | LTBP2 | 1.63 |
| 487 | Carpal tunnel syndrome 2 | Enrichment | COMP | 1.63 |
| 488 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 | Enrichment | ACTG2 | 1.63 |
| 489 | Basal ganglia calcification, idiopathic, 8, autosomal recessive | Enrichment | JAM2 | 1.63 |
| 490 | Neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus | Enrichment | TNR | 1.63 |
| 491 | Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency | Enrichment | MUSK | 1.63 |
| 492 | Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis 2 | Enrichment | DTNA | 1.63 |
| 493 | Neuronopathy, distal hereditary motor, autosomal dominant 10 | Enrichment | EMILIN1 | 1.63 |
| 494 | Cutis laxa, autosomal recessive, type id | Enrichment | EFEMP1 | 1.63 |
| 495 | Von willebrand disease, type 3 | Enrichment | VWF | 1.63 |
| 496 | Fetomaternal alloimmune thrombocytopenia 2 | Enrichment | ITGA2B | 1.63 |
| 497 | Meester-loeys syndrome | Enrichment | BGN | 1.63 |
| 498 | Congenital smooth muscle hamartoma, with or without hemihypertrophy | Enrichment | ACTB | 1.63 |
| 499 | Cardiomyopathy, dilated, 3b | Enrichment | DMD | 1.63 |
| 500 | Cardiomyopathy, dilated, 1l | Enrichment | SGCD | 1.63 |
| 501 | Pitt-hopkins-like syndrome 2 | Enrichment | NRXN1 | 1.63 |
| 502 | Microphthalmia, syndromic 6 | Enrichment | BMP4 | 1.63 |
| 503 | Synpolydactyly 2 | Enrichment | FBLN1 | 1.63 |
| 504 | Spondylometaepiphyseal dysplasia, short limb-hand type | Enrichment | DDR2 | 1.63 |
| 505 | Orofacial cleft 11 | Enrichment | BMP4 | 1.63 |
| 506 | Plasminogen activator inhibitor-1 deficiency | Enrichment | SERPINE1 | 1.63 |
| 507 | Aortic aneurysm, familial thoracic 9 | Enrichment | MFAP5 | 1.63 |
| 508 | Left ventricular noncompaction 1 | Enrichment | DTNA | 1.63 |
| 509 | Camurati-engelmann disease 2 | Enrichment | TGFB2 | 1.63 |
| 510 | Geleophysic dysplasia 3 | Enrichment | LTBP3 | 1.63 |
| 511 | Cerebral amyloid angiopathy, app-related | Enrichment | APP | 1.63 |
| 512 | Becker nevus syndrome | Enrichment | ACTB | 1.63 |
| 513 | Dystonia-deafness syndrome 1 | Enrichment | ACTB | 1.63 |
| 514 | Visceral neuropathy, familial, 3, autosomal dominant | Enrichment | ACTG2 | 1.63 |
| 515 | Autosomal recessive limb-girdle muscular dystrophy type 2c | Enrichment | SGCG | 1.63 |
| 516 | Long qt syndrome 12 | Enrichment | SNTA1 | 1.63 |
| 517 | Cortical malformations, occipital | Enrichment | LAMC3 | 1.63 |
| 518 | Congenital myopathy 2b, severe infantile, autosomal recessive | Enrichment | ACTA1 | 1.63 |
| 519 | Cutis laxa, autosomal dominant 2 | Enrichment | FBLN5 | 1.63 |
| 520 | Bleeding disorder, platelet-type, 15 | Enrichment | ACTN1 | 1.63 |
| 521 | Chromosome 2p16.3 deletion syndrome | Enrichment | NRXN1 | 1.63 |
| 522 | Autosomal dominant familial visceral neuropathy | Enrichment | ACTG2 | 1.63 |
| 523 | Hemorrhagic destruction of the brain, subependymal calcification, and cataracts | Enrichment | JAM3 | 1.63 |
| 524 | Muscular dystrophy-dystroglycanopathy , type c, 9 | Enrichment | DAG1 | 1.63 |
| 525 | Loeys-dietz syndrome 5 | Enrichment | TGFB3 | 1.63 |
| 526 | 20p12.3 microdeletion syndrome | Enrichment | BMP2 | 1.63 |
| 527 | Cutis laxa, autosomal recessive, type iie | Enrichment | LTBP1 | 1.63 |
| 528 | Autosomal recessive limb-girdle muscular dystrophy type 2f | Enrichment | SGCD | 1.63 |
| 529 | Congenital myopathy 2c, severe infantile, autosomal dominant | Enrichment | ACTA1 | 1.63 |
| 530 | Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1 | Enrichment | BMP2 | 1.63 |
| 531 | Von willebrand's disease | Enrichment | VWF | 1.63 |
| 532 | Thrombocytopenia 8, with dysmorphic features and developmental delay | Enrichment | ACTB | 1.63 |
| 533 | Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy | Enrichment | TRAPPC4 | 1.63 |
| 534 | Charcot-marie-tooth disease, demyelinating, type 1h | Enrichment | FBLN5 | 1.63 |
| 535 | Nrxn1-related severe neurodevelopmental disorder-motor stereotypies-chronic constipation-sleep-wake cycle disturbance | Enrichment | NRXN1 | 1.63 |
| 536 | Warburg-cinotti syndrome | Enrichment | DDR2 | 1.63 |
| 537 | Tufted angioma of skin | Enrichment | KDR | 1.63 |
| 538 | Amelogenesis imperfecta, type ih | Enrichment | ITGB6 | 1.63 |
| 539 | Baraitser-winter syndrome | Enrichment | ACTB | 1.63 |
| 540 | Amyloidosis | Enrichment | TTR | 1.63 |
| 541 | Occipital pachygyria and polymicrogyria | Enrichment | LAMC3 | 1.63 |
| 542 | Glaucoma secondary to spherophakia/ectopia lentis and megalocornea | Enrichment | LTBP2 | 1.63 |
| 543 | Symptomatic form of muscular dystrophy of duchenne and becker in female carriers | Enrichment | DMD | 1.63 |
| 544 | Cask-related intellectual disability | Enrichment | CASK | 1.63 |
| 545 | Qualitative or quantitative defects of sarcoglycan | Enrichment | SGCA | 1.63 |
| 546 | Fetomaternal alloimmune thrombocytopenia 3 | Enrichment | ITGA2 | 1.63 |
| 547 | Immune dysregulation, neurodevelopmental defects, and colitis | Enrichment | ITGAV | 1.63 |
| 548 | Zebra body myopathy | Enrichment | ACTA1 | 1.63 |
| 549 | Congenital smooth muscle hamartoma | Enrichment | ACTB | 1.63 |
| 550 | Duchenne and becker muscular dystrophy | Enrichment | DMD | 1.63 |
| 551 | Developmental malformations-deafness-dystonia syndrome | Enrichment | ACTB | 1.63 |
| 552 | Arterial tortuosity-bone fragility syndrome | Enrichment | EMILIN1 | 1.63 |
| 553 | Congenital plasminogen activator inhibitor type 1 deficiency | Enrichment | SERPINE1 | 1.63 |
| 554 | Lethal arteriopathy syndrome due to fibulin-4 deficiency | Enrichment | EFEMP2 | 1.63 |
| 555 | Fbln1-related developmental delay-central nervous system anomaly-syndactyly syndrome | Enrichment | FBLN1 | 1.63 |
| 556 | Muscle-eye-brain disease with bilateral multicystic leucodystrophy | Enrichment | DAG1 | 1.63 |
| 557 | Hereditary amyloidosis | Enrichment | TTR | 1.63 |
| 558 | Actin-accumulation myopathy | Enrichment | ACTA1 | 1.63 |
| 559 | Attrv30m amyloidosis | Enrichment | TTR | 1.63 |
| 560 | Myopathic intestinal pseudoobstruction | Enrichment | ACTG2 | 1.63 |
| 561 | Porencephaly-microcephaly-bilateral congenital cataract syndrome | Enrichment | JAM3 | 1.63 |
| 562 | Emilin-1-related connective tissue disease | Enrichment | EMILIN1 | 1.63 |
| 563 | Hereditary sensorimotor neuropathy with hyperelastic skin | Enrichment | FBLN5 | 1.63 |
| 564 | Qualitative or quantitative defects of dystrophin | Enrichment | DMD | 1.63 |
| 565 | Actg2 visceral myopathy | Enrichment | ACTG2 | 1.63 |
| 566 | Laminin subunit alpha 2-related muscular dystrophy | Enrichment | LAMA2 | 1.63 |
| 567 | Attrv122i amyloidosis | Enrichment | TTR | 1.63 |
| 568 | Brittle cornea syndrome 1 | Enrichment | PLOD1 | 1.61 |
| 569 | Rare isolated myopia | Enrichment | P3H2 | 1.61 |
| 570 | Gastroesophageal reflux | Enrichment | COL5A1 | 1.59 |
| 571 | Pectus excavatum | Enrichment | DMD, FBN1 | 1.58 |
| 572 | Amyloidosis, hereditary systemic 2 | Enrichment | FGA | 1.57 |
| 573 | Rare genetic deafness | Enrichment | COL11A2, COL4A5 | 1.57 |
| 574 | Achondroplasia | Enrichment | FBN1 | 1.52 |
| 575 | Type 1 diabetes mellitus 2 | Enrichment | CAPN10 | 1.52 |
| 576 | Dyssegmental dysplasia, silverman-handmaker type | Enrichment | HSPG2 | 1.52 |
| 577 | Glomerulopathy with fibronectin deposits 2 | Enrichment | FN1 | 1.52 |
| 578 | Alzheimer disease 4 | Enrichment | PSEN1 | 1.52 |
| 579 | Body mass index quantitative trait locus 12 | Enrichment | CAST | 1.52 |
| 580 | Proprotein convertase 1/3 deficiency | Enrichment | CAST | 1.52 |
| 581 | Muscular dystrophy, limb-girdle, autosomal dominant 4 | Enrichment | CAPN3 | 1.52 |
| 582 | Autosomal recessive limb-girdle muscular dystrophy type 2a | Enrichment | CAPN3 | 1.52 |
| 583 | Isolated ectopia lentis | Enrichment | FBN1 | 1.52 |
| 584 | Isolated dandy-walker malformation without hydrocephalus | Enrichment | NID1 | 1.52 |
| 585 | Epidermolysis bullosa simplex | Enrichment | ITGB4 | 1.51 |
| 586 | Amelogenesis imperfecta type 2 | Enrichment | MMP20 | 1.51 |
| 587 | Muscular dystrophy, limb-girdle, autosomal recessive 2 | Enrichment | CAPN3, SGCB | 1.51 |
| 588 | Atypical hemolytic uremic syndrome with complement gene abnormality | Enrichment | THBD | 1.50 |
| 589 | Neutropenia | Enrichment | ELANE | 1.49 |
| 590 | Alzheimer's disease | Enrichment | APP, PSEN1 | 1.44 |
| 591 | Cakut | Enrichment | COL4A1 | 1.43 |
| 592 | Genetic steroid-resistant nephrotic syndrome | Enrichment | COL4A3 | 1.43 |
| 593 | Cystic fibrosis | Enrichment | CEACAM6, PLG, TGFB1 | 1.42 |
| 594 | Aortic aneurysm | Enrichment | FBN1 | 1.40 |
| 595 | Mitral valve insufficiency | Enrichment | FBN1 | 1.40 |
| 596 | Pediatric systemic lupus erythematosus | Enrichment | SPP1 | 1.40 |
| 597 | Cerebral amyloid angiopathy, cst3-related | Enrichment | APP | 1.33 |
| 598 | Leukocyte adhesion deficiency, type i | Enrichment | ITGB2 | 1.33 |
| 599 | Wagner vitreoretinopathy | Enrichment | VCAN | 1.33 |
| 600 | Camurati-engelmann disease 1 | Enrichment | TGFB1 | 1.33 |
| 601 | Spondyloepimetaphyseal dysplasia, x-linked | Enrichment | BGN | 1.33 |
| 602 | Myasthenic syndrome, congenital, 5 | Enrichment | LAMB2 | 1.33 |
| 603 | Fg syndrome 4 | Enrichment | CASK | 1.33 |
| 604 | Epiphyseal dysplasia, multiple, 5 | Enrichment | MATN3 | 1.33 |
| 605 | Aortic aneurysm, familial thoracic 2 | Enrichment | ACTA2 | 1.33 |
| 606 | Doyne honeycomb retinal dystrophy | Enrichment | EFEMP1 | 1.33 |
| 607 | Cardiomyopathy, dilated, 1r | Enrichment | ACTC1 | 1.33 |
| 608 | Muscular dystrophy, limb-girdle, autosomal recessive 4 | Enrichment | SGCB | 1.33 |
| 609 | Deafness, autosomal dominant 20 | Enrichment | ACTG1 | 1.33 |
| 610 | Multiple synostoses syndrome 2 | Enrichment | GDF5 | 1.33 |
| 611 | Cardiomyopathy, familial hypertrophic, 11 | Enrichment | ACTC1 | 1.33 |
| 612 | Smooth muscle dysfunction syndrome | Enrichment | ACTA2 | 1.33 |
| 613 | Leukocyte adhesion deficiency, type iii | Enrichment | ITGB2 | 1.33 |
| 614 | Cutis laxa, autosomal recessive, type ic | Enrichment | LTBP4 | 1.33 |
| 615 | Aortic aneurysm, familial thoracic 6 | Enrichment | ACTA2 | 1.33 |
| 616 | Mononeuropathy of the median nerve, mild | Enrichment | TTR | 1.33 |
| 617 | Baraitser-winter syndrome 2 | Enrichment | ACTG1 | 1.33 |
| 618 | Angioma, tufted | Enrichment | KDR | 1.33 |
| 619 | Moyamoya disease 5 | Enrichment | ACTA2 | 1.33 |
| 620 | Muscular dystrophy, limb-girdle, autosomal recessive 3 | Enrichment | SGCA | 1.33 |
| 621 | Spondyloepimetaphyseal dysplasia, borochowitz-cormier-daire type | Enrichment | MATN3 | 1.33 |
| 622 | Pierson syndrome | Enrichment | LAMB2 | 1.33 |
| 623 | Sclerosteosis 2 | Enrichment | LRP4 | 1.33 |
| 624 | Brachydactyly, type a1, c | Enrichment | GDF5 | 1.33 |
| 625 | Symphalangism, proximal, 1b | Enrichment | GDF5 | 1.33 |
| 626 | Atrial septal defect 5 | Enrichment | ACTC1 | 1.33 |
| 627 | Inflammatory bowel disease, immunodeficiency, and encephalopathy | Enrichment | TGFB1 | 1.33 |
| 628 | Nephrotic syndrome, type 5, with or without ocular abnormalities | Enrichment | LAMB2 | 1.33 |
| 629 | Autosomal recessive limb-girdle muscular dystrophy type 2d | Enrichment | SGCA | 1.33 |
| 630 | Autosomal recessive hypophosphatemic rickets | Enrichment | DMP1 | 1.33 |
| 631 | Sclerosteosis | Enrichment | LRP4 | 1.33 |
| 632 | Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome | Enrichment | ITGA3 | 1.33 |
| 633 | Syndromic x-linked intellectual disability | Enrichment | CASK | 1.33 |
| 634 | Optic disk drusen | Enrichment | EFEMP1 | 1.33 |
| 635 | Osteogenesis imperfecta, type xvii | Enrichment | SPARC | 1.33 |
| 636 | Camurati-engelmann disease | Enrichment | TGFB1 | 1.33 |
| 637 | Myasthenic syndrome, congenital, 17 | Enrichment | LRP4 | 1.33 |
| 638 | Degenerative disc disease | Enrichment | ASPN | 1.33 |
| 639 | Proximal symphalangism | Enrichment | GDF5 | 1.33 |
| 640 | Craniosynostosis 7 | Enrichment | BMP2 | 1.33 |
| 641 | Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies | Enrichment | TRAPPC4 | 1.33 |
| 642 | Wagner disease | Enrichment | VCAN | 1.33 |
| 643 | Qualitative or quantitative defects of beta-sarcoglycan | Enrichment | SGCB | 1.33 |
| 644 | Glycoproteinosis | Enrichment | SGCB | 1.33 |
| 645 | Sgce myoclonus-dystonia | Enrichment | SGCE | 1.33 |
| 646 | Intestinal obstruction | Enrichment | ACTG2 | 1.33 |
| 647 | Congenital myopathy 4a, autosomal dominant | Enrichment | ACTA1, ITGA7 | 1.33 |
| 648 | Hydrocephalus | Enrichment | NID1, PLOD1 | 1.33 |
| 649 | Polycystic liver disease 1 with or without kidney cysts | Enrichment | FBN1 | 1.30 |
| 650 | Arthrogryposis, renal dysfunction, and cholestasis 1 | Enrichment | FBN1 | 1.30 |
| 651 | Vitamin d-dependent rickets, type 2a | Enrichment | PRSS1 | 1.30 |
| 652 | Goldberg-shprintzen syndrome | Enrichment | FBN1 | 1.30 |
| 653 | Autosomal recessive limb-girdle muscular dystrophy type 2b | Enrichment | CAPN3 | 1.30 |
| 654 | Polycystic liver disease 1 | Enrichment | FBN1 | 1.30 |
| 655 | Dementia | Enrichment | PSEN1 | 1.30 |
| 656 | Cleft palate, isolated | Enrichment | COL11A1 | 1.27 |
| 657 | Fetal akinesia deformation sequence 1 | Enrichment | ACTA1, FBN2, MUSK | 1.26 |
| 658 | Bilirubin metabolic disorder | Enrichment | F12 | 1.24 |
| 659 | Alzheimer disease, familial, 1 | Enrichment | APP, PSEN1 | 1.23 |
| 660 | Spondyloepiphyseal dysplasia with congenital joint dislocations | Enrichment | ACAN | 1.23 |
| 661 | Telangiectasia, hereditary hemorrhagic, type 1 | Enrichment | PSEN1 | 1.23 |
| 662 | Muscular dystrophy, limb-girdle, autosomal recessive 1 | Enrichment | CAPN3 | 1.23 |
| 663 | 46,xy disorder of sex development | Enrichment | ADAMTS16 | 1.23 |
| 664 | Neuromuscular disease | Enrichment | ACTA1, SGCD | 1.18 |
| 665 | Neuronal ceroid lipofuscinosis | Enrichment | CTSD | 1.16 |
| 666 | Brachydactyly, type a1 | Enrichment | GDF5 | 1.16 |
| 667 | Hyper-ige syndrome 1, autosomal dominant, with recurrent infections | Enrichment | ITGB3 | 1.16 |
| 668 | Brachydactyly, type c | Enrichment | GDF5 | 1.16 |
| 669 | Arterial tortuosity syndrome | Enrichment | EMILIN1 | 1.16 |
| 670 | Acromesomelic dysplasia 2a | Enrichment | GDF5 | 1.16 |
| 671 | Acromesomelic dysplasia 2c | Enrichment | GDF5 | 1.16 |
| 672 | Acromesomelic dysplasia 2b | Enrichment | GDF5 | 1.16 |
| 673 | Periventricular nodular heterotopia 1 | Enrichment | VWF | 1.16 |
| 674 | Intellectual developmental disorder with microcephaly and pontine and cerebellar hypoplasia | Enrichment | CASK | 1.16 |
| 675 | Ehlers-danlos syndrome, classic-like, 1 | Enrichment | TNXB | 1.16 |
| 676 | Transposition of the great arteries, dextro-looped | Enrichment | BMP2 | 1.16 |
| 677 | Muscular dystrophy, congenital merosin-deficient, 1a | Enrichment | LAMA2 | 1.16 |
| 678 | Muscular dystrophy, congenital, due to integrin alpha-7 deficiency | Enrichment | ITGA7 | 1.16 |
| 679 | Cenani-lenz syndactyly syndrome | Enrichment | LRP4 | 1.16 |
| 680 | Vesicoureteral reflux 8 | Enrichment | TNXB | 1.16 |
| 681 | Bronchopulmonary dysplasia | Enrichment | MUSK | 1.16 |
| 682 | Cutis laxa, autosomal recessive, type ib | Enrichment | EFEMP2 | 1.16 |
| 683 | Poretti-boltshauser syndrome | Enrichment | LAMA1 | 1.16 |
| 684 | Syndromic x-linked intellectual disability najm type | Enrichment | CASK | 1.16 |
| 685 | Cerebellar disease | Enrichment | CASK | 1.16 |
| 686 | Familial vesicoureteral reflux | Enrichment | TNXB | 1.16 |
| 687 | Bleeding disorder, platelet-type, 24 | Enrichment | ITGB3 | 1.16 |
| 688 | Alopecia - intellectual disability syndrome | Enrichment | ITGB6 | 1.16 |
| 689 | Familial drusen | Enrichment | EFEMP1 | 1.16 |
| 690 | Lama2-related muscular dystrophy | Enrichment | LAMA2 | 1.16 |
| 691 | Brugada syndrome 1 | Enrichment | FBN1 | 1.16 |
| 692 | Semantic dementia | Enrichment | PSEN1 | 1.16 |
| 693 | Focal epilepsy | Enrichment | NID1 | 1.16 |
| 694 | Charcot-marie-tooth disease | Enrichment | DST, LAMA2, TTR | 1.15 |
| 695 | Distal arthrogryposis | Enrichment | ACTA1, ACTC1, COL25A1 | 1.12 |
| 696 | Ear malformation | Enrichment | COL11A2 | 1.12 |
| 697 | Progressive non-fluent aphasia | Enrichment | PSEN1 | 1.06 |
| 698 | Limb-girdle muscular dystrophy | Enrichment | CAPN3 | 1.06 |
| 699 | Behavioral variant of frontotemporal dementia | Enrichment | PSEN1 | 1.06 |
| 700 | Amelogenesis imperfecta, type iiia | Enrichment | ITGB6 | 1.04 |
| 701 | Nemaline myopathy 2 | Enrichment | ACTA1 | 1.04 |
| 702 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 1 | Enrichment | ACTG2 | 1.04 |
| 703 | Autoimmune lymphoproliferative syndrome | Enrichment | ACTA2 | 1.04 |
| 704 | Glaucoma 3, primary infantile, b | Enrichment | LTBP2 | 1.04 |
| 705 | Retinitis pigmentosa 26 | Enrichment | ITGA4 | 1.04 |
| 706 | Dentin dysplasia, type i | Enrichment | DSPP | 1.04 |
| 707 | Aminoacylase 1 deficiency | Enrichment | ACTB | 1.04 |
| 708 | Multiple synostoses syndrome | Enrichment | GDF5 | 1.04 |
| 709 | Atrial fibrillation | Enrichment | SNTA1 | 1.04 |
| 710 | Diabetes insipidus | Enrichment | MATN4 | 1.04 |
| 711 | Cerebral malaria | Enrichment | ICAM1 | 1.04 |
| 712 | Intermediate nemaline myopathy | Enrichment | ACTA1 | 1.04 |
| 713 | Melanoma | Enrichment | FBN1 | 1.01 |
| 714 | Migraine with or without aura 1 | Enrichment | CAPN3 | 0.97 |
| 715 | Frontotemporal dementia 1 | Enrichment | PSEN1 | 0.97 |
| 716 | Autoinflammatory disease | Enrichment | ELANE | 0.97 |
| 717 | Arrhythmogenic right ventricular dysplasia, familial, 1 | Enrichment | TGFB3 | 0.95 |
| 718 | Visceral myopathy 1 | Enrichment | ACTG2 | 0.95 |
| 719 | Anemia, congenital, nonspherocytic hemolytic, 1 | Enrichment | CASK | 0.95 |
| 720 | Congenital myopathy 3 with rigid spine | Enrichment | ACTA1 | 0.95 |
| 721 | Myasthenic syndrome, congenital, 8 | Enrichment | AGRN | 0.95 |
| 722 | Congenital heart defects, multiple types, 4 | Enrichment | BMP7 | 0.95 |
| 723 | Glanzmann thrombasthenia 2 | Enrichment | ITGB3 | 0.95 |
| 724 | Muscular dystrophy, limb-girdle, autosomal recessive 23 | Enrichment | LAMA2 | 0.95 |
| 725 | Holoprosencephaly | Enrichment | MATN4 | 0.95 |
| 726 | Night blindness | Enrichment | EFEMP1 | 0.95 |
| 727 | Arrhythmogenic right ventricular dysplasia 1 | Enrichment | TGFB3 | 0.95 |
| 728 | Coloboma of choroid and retina | Enrichment | ACTG1 | 0.95 |
| 729 | Severe congenital nemaline myopathy | Enrichment | ACTA1 | 0.95 |
| 730 | Body mass index quantitative trait locus 11 | Enrichment | CAST, NRXN1, SDC3 | 0.95 |
| 731 | Microphthalmia/coloboma 12 | Enrichment | CAPN15 | 0.90 |
| 732 | Diaphragmatic hernia, congenital | Enrichment | FBN1 | 0.90 |
| 733 | Chromosome 1p36 deletion syndrome | Enrichment | HSPG2 | 0.90 |
| 734 | Nonsyndromic hearing loss | Enrichment | COL11A2 | 0.89 |
| 735 | Glaucoma, primary open angle | Enrichment | LTBP2 | 0.88 |
| 736 | Dystonia 11, myoclonic | Enrichment | SGCE | 0.88 |
| 737 | Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency | Enrichment | TNXB | 0.88 |
| 738 | Holoprosencephaly 1 | Enrichment | MATN4 | 0.88 |
| 739 | Moyamoya disease 1 | Enrichment | ACTA2 | 0.88 |
| 740 | Hemangioma, capillary infantile | Enrichment | KDR | 0.88 |
| 741 | Dental anomalies and short stature | Enrichment | LTBP3 | 0.88 |
| 742 | Inflammatory bowel disease 25, autosomal recessive | Enrichment | TGFB1 | 0.88 |
| 743 | Intestinal pseudo-obstruction | Enrichment | ACTG2 | 0.88 |
| 744 | Il10-related early-onset inflammatory bowel disease | Enrichment | TGFB1 | 0.88 |
| 745 | Typical nemaline myopathy | Enrichment | ACTA1 | 0.88 |
| 746 | 21-hydroxylase-deficient congenital adrenal hyperplasia | Enrichment | TNXB | 0.88 |
| 747 | Heart disease | Enrichment | CAPN15 | 0.87 |
| 748 | Hereditary chronic pancreatitis | Enrichment | PRSS1 | 0.87 |
| 749 | Coloboma of macula | Enrichment | CAPN15 | 0.85 |
| 750 | Severe covid-19 | Enrichment | F13B | 0.84 |
| 751 | Perrault syndrome 1 | Enrichment | FBN1 | 0.82 |
| 752 | Meniere disease | Enrichment | DTNA | 0.82 |
| 753 | Alzheimer's disease 1 | Enrichment | APP | 0.82 |
| 754 | Childhood-onset nemaline myopathy | Enrichment | ACTA1 | 0.82 |
| 755 | Congenital hydrocephalus | Enrichment | SGCD | 0.82 |
| 756 | Hypophosphatemic rickets | Enrichment | DMP1 | 0.82 |
| 757 | Primary ovarian insufficiency | Enrichment | ADAMTS1, KDR, THBS1 | 0.80 |
| 758 | Hemochromatosis, type 1 | Enrichment | BMP2 | 0.76 |
| 759 | Renal hypodysplasia/aplasia 1 | Enrichment | ITGA8 | 0.76 |
| 760 | Familial hypertrophic cardiomyopathy | Enrichment | ACTC1, DMD | 0.74 |
| 761 | Williams-beuren syndrome | Enrichment | ELN | 0.73 |
| 762 | Renal agenesis, bilateral | Enrichment | ITGA8 | 0.72 |
| 763 | Left ventricular noncompaction | Enrichment | ACTC1, DTNA | 0.70 |
| 764 | Non-syndromic x-linked intellectual disability | Enrichment | CASK, DMD | 0.69 |
| 765 | Autism | Enrichment | COL11A1 | 0.68 |
| 766 | Cat eye syndrome | Enrichment | ACTG1 | 0.68 |
| 767 | Myasthenic syndrome, congenital, 4c, associated with acetylcholine receptor deficiency | Enrichment | MUSK | 0.68 |
| 768 | Nemaline myopathy | Enrichment | ACTA1 | 0.68 |
| 769 | Meningioma, familial | Enrichment | PDGFB | 0.64 |
| 770 | Atrial heart septal defect | Enrichment | DMD | 0.64 |
| 771 | Movement disease | Enrichment | SGCE | 0.64 |
| 772 | Interatrial communication | Enrichment | DMD | 0.64 |
| 773 | Systemic lupus erythematosus | Enrichment | ITGAM, SPP1 | 0.63 |
| 774 | Renal hypodysplasia/aplasia 3 | Enrichment | BMP4 | 0.61 |
| 775 | Meningioma | Enrichment | PDGFB | 0.61 |
| 776 | Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant | Enrichment | TGFB3 | 0.61 |
| 777 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant | Enrichment | TGFB3 | 0.61 |
| 778 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | COL11A2 | 0.60 |
| 779 | Retinitis pigmentosa | Enrichment | ADAM9, COL18A1 | 0.58 |
| 780 | Neural tube defects | Enrichment | ITGB1 | 0.58 |
| 781 | Nk-cell enteropathy | Enrichment | PTPRS | 0.58 |
| 782 | Cone-rod dystrophy 2 | Enrichment | ADAM9 | 0.56 |
| 783 | Lipoid congenital adrenal hyperplasia | Enrichment | TNXB | 0.55 |
| 784 | Lung cancer susceptibility 3 | Enrichment | ACTA2 | 0.55 |
| 785 | Congenital myasthenic syndrome | Enrichment | AGRN | 0.55 |
| 786 | Cleft lip/palate | Enrichment | BMP4 | 0.55 |
| 787 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant | Enrichment | TGFB3 | 0.55 |
| 788 | Nephronophthisis | Enrichment | ADAMTS9 | 0.54 |
| 789 | Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay | Enrichment | CASK | 0.50 |
| 790 | Isolated congenital microcephaly | Enrichment | CASK | 0.50 |
| 791 | Early infantile developmental and epileptic encephalopathy | Enrichment | CASK | 0.46 |
| 792 | Congenital myopathy | Enrichment | ACTA1 | 0.44 |
| 793 | Lissencephaly | Enrichment | ACTG1 | 0.41 |
| 794 | Centronuclear myopathy | Enrichment | ACTA1 | 0.41 |
| 795 | Schizophrenia | Enrichment | DMD, NRXN1 | 0.39 |
| 796 | Malaria | Enrichment | ICAM1 | 0.38 |
| 797 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 | Enrichment | PSEN1 | 0.35 |
| 798 | Tetralogy of fallot | Enrichment | KDR | 0.34 |
| 799 | Hydrops fetalis, nonimmune | Enrichment | ACTA1 | 0.34 |
| 800 | Long qt syndrome 1 | Enrichment | SNTA1 | 0.29 |
| 801 | Long qt syndrome | Enrichment | SNTA1 | 0.28 |
| 802 | Non-immune hydrops fetalis | Enrichment | ACTA1 | 0.28 |
| 803 | Lung cancer | Enrichment | ACTA2 | 0.27 |
| 804 | Fanconi anemia, complementation group a | Enrichment | DMD | 0.25 |
| 805 | Dystonia | Enrichment | CASK | 0.25 |
| 806 | Non-syndromic genetic deafness | Enrichment | ACTG1 | 0.24 |
| 807 | Hypertrophic cardiomyopathy | Enrichment | ACTC1 | 0.19 |
| 808 | Congenital nervous system abnormality | Enrichment | PSEN1 | 0.18 |
| 809 | Nervous system disease | Enrichment | PSEN1 | 0.18 |
| 810 | Colorectal cancer | Enrichment | DMD | 0.06 |
| 811 | Autism spectrum disorder | Enrichment | NRXN1 | 0.03 |
| 812 | Complex neurodevelopmental disorder | Enrichment | TRAPPC4 | 0.02 |